The repurchase program is routine and pre-announced. No new strategic or financial signals — monitor next earnings release for fundamental trends and guidance updates.
Price Chart
Executive Summary
Novo Nordisk filed a 6-K to report ongoing share repurchase activity under a pre-announced program. Since 4 February 2026, the company has repurchased 17,049,028 B shares at an average price of DKK 262.22 for a total value of DKK 4.47 billion, as part of a DKK 15 billion program. The filing is a routine operational update on capital allocation with no material financial data, guidance changes, or strategic announcements.
Key Facts
- Novo Nordisk has repurchased 17,049,028 B shares at an average price of DKK 262.22 per share since 4 February 2026 for a total of DKK 4,470,560,295.
- The overall buyback program allows for up to DKK 15 billion in repurchases over a 12-month period ending 1 February 2027.
- As of 22 May 2026, the company holds 34,234,329 B shares as treasury shares, representing 0.8% of total share capital.
- No financial results, guidance updates, or material operational changes were reported in this filing.
Financial Impact
DKK 4.47 billion repurchased so far vs. DKK 15 billion authorization
Risk Factors
- Competition in obesity/diabetes market could pressure growth
- Upcoming semaglutide loss of exclusivity in certain markets
- Workforce reduction and restructuring overhang
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-003710 |
| Document: 0001171843-26-003710-index-headers.html | 0001171843-26-003710 |
| Document: 0001171843-26-003710-index.html | 0001171843-26-003710 |
| Document: 0001171843-26-003710.txt | 0001171843-26-003710 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 8, 2026 20w ago | 6-K | $41.25 $46.09 | ▲ +11.73% | ▲ +8.42% | $38.98 (−5.50%) |
May 27, 2026 21w ago | 6-K | $44.80 $46.30 | ▲ +3.35% | ▲ +1.47% | $38.98 (−12.99%) |
May 22, 2026 22w ago | 6-K | $43.80 $44.78 | ▲ +2.24% | ▼ −0.95% | $38.98 (−11.00%) |
Apr 13, 2026 28w ago | 6-K | $38.08 $49.85 | ▲ +30.91% | ▲ +21.99% | $38.98 (+2.36%) |
Apr 7, 2026 29w ago | 6-K | $35.92 $50.00 | ▲ +39.20% | ▲ +25.93% | $38.98 (+8.52%) |
Mar 27, 2026 30w ago | 6-K | $35.29 $46.84 | ▲ +32.73% | ▲ +16.66% | $38.98 (+10.46%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers